Inhibikase Therapeutics Inc - Netong Asset Bawat Isang Bahagi IKT
Ang pag-aabang sa mga resulta ng Phase II trial para sa isang gamot sa sakit na Parkinson ay nagpapataas ng interes sa Inhibikase Therapeutics (IKT), kung saan ang kasalukuyang indicator ay nasa 1.16. Ang chart na ito ng kasalukuyang share price ay sumasalamin sa dynamics ng kumpanya, na bumubuo ng isang neurodegeneration therapy system sa pamamagitan ng mga kinase inhibitor. Ang negosyo ay nakasalalay sa precision delivery ng mga biomaterials, habang ang isang partnership sa isang laboratory network ay nagsisiguro ng katatagan ng supply at mataas na profitability.
inhibikase.com - mga analytical breakdown at pangunahing sukatan (IKT)
- presyo at pagtataya ng pinagkasunduang presyo:
- datos sa market capitalization:
- datos sa book capitalization:
- datos sa utang at liquidity:
Utang sa Stockholders Equity Inhibikase Therapeutics|IKT - Coefficient ng pangmatagalang utang sa kapital|Panandaliang utang sa equity Inhibikase Therapeutics, Inc.|IKT - Kabuuang halaga ng utang ng kumpanya|Mga utang sa book capitalization Inhibikase Therapeutics, Inc.|IKT - Laki ng pangmatagalang utang|Panandaliang utang ng kumpanya Inhibikase Therapeutics
Pagsusuri ng lahat ng sukatan ng kumpanya:Inhibikase IKT
Ang book value per share ay sumasalamin sa net equity ng kumpanya minus lahat ng liabilities, na nagpapahintulot sa aggregate book value per security na tukuyin ang fundamental basis ng asset sa panahon ng market volatility. Para sa Inhibikase Therapeutics (IKT), ang kalkuladong indicator na ito ay nagpapakita ng aktwal na tangible backing ng bawat share, na kritikal kapag sinusuri ang halaga ng isang highly specialized scientific staff at mga long-term researcher option programs.
Pagsusuri ng mga kakumpitensya ng Inhibikase Therapeutics
Accounting Book Value Bawat Bahagi Biogen Corp BIIB|NBIX: Book Price ng Bahagi|Netong Asset Bawat Isang Bahagi Regencell Bioscience|axsome.com (AXSM) - Stockholders Equity Bawat Bahagi|Book Value Bawat Bahagi ACAD (ACADIA Pharmaceuticals Inc.)|Net Asset Value Bawat Bahagi Xenon Pharmaceuticals Inc. (XENE)|Accounting Book Value Bawat Bahagi VKTX|Book Value Bawat Bahagi SUPN (Supernus Corp)|Netong Asset Bawat Isang Bahagi Catalyst Pharmaceuticals|denalitherapeutics.com - Accounting Value ng Bahagi|HRMY (Harmony Biosciences Holdings, Inc.) - Netong Asset Bawat Isang Bahagi|BHVN - Net Asset Value Bawat Bahagi|Amylyx - Book Value Bawat Bahagi|TRVI (Trevi Corp) - Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi Praxis Precision Medicines (PRAX)|Stockholders Equity Bawat Bahagi anavex.com|CeriBell (CBLL) - Book Value Bawat Bahagi|Accounting Value ng Bahagi Prothena Corporation (PRTA)|Book Value Bawat Bahagi ALEC|Net Assets Bawat Bahagi Annexon Biosciences Inc. ANNX|OMER - Book Value Bawat Bahagi|NGNE - Netong Asset Bawat Isang Bahagi|AC Immune SA - Book Value Bawat Bahagi|VYGR (Voyager Therapeutics Inc) - Net Assets Bawat Bahagi|NMRA (Neumora Therapeutics Inc) - Netong Asset Bawat Isang Bahagi|Book Value Bawat Bahagi Scilex Holding Company, Inc.|Book Value Bawat Bahagi TVGN|Book Value Bawat Bahagi ACOG (alphacognition.com)|Netong Asset Bawat Isang Bahagi CGTX|Net Assets Bawat Bahagi Cassava Sciences Inc SAVA|ASRT (Assertio Therapeutics) - Book Value Bawat Bahagi|Coya Therapeutics, Inc. (COYA) - Net Asset Value Bawat Bahagi|Accounting Book Value Bawat Bahagi vistagen.com VTGN|Accounting Value ng Bahagi Ovid Therapeutics|Acumen Pharmaceuticals, Inc. (ABOS) - Accounting Book Value Bawat Bahagi|Book Price ng Bahagi CervoMed, Inc.|Alterity Therapeutics (ATHE) - Book Value Bawat Bahagi|Accounting Value ng Bahagi clene.com (CLNN)|PEPG: Book Value Bawat Bahagi|Jupiter Neurosciences, Inc. - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Relmada Therapeutics, Inc. (RLMD)|ANVS - Accounting Value ng Bahagi|GRCE: Book Value Bawat Bahagi|AIFF (Firefly Neuro) - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi ANEW Medical KLTO|Book Value ng Bahagi NeuroSense Therapeutics, Ltd.|Reviva Pharmaceuticals Holdings, Inc. - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi metaviatx.com MTVA|Accounting Book Value Bawat Bahagi NRXS (NeurAxis, Inc)|HSDT - Book Value Bawat Bahagi|Accounting Book Value Bawat Bahagi Passage Bio Corp PASG|NEUP - Book Price ng Bahagi|Minerva Neurosciences, Inc. - Book Value Bawat Bahagi|Athira Pharma Inc (ATHA) - Net Assets Bawat Bahagi|Book Value Bawat Bahagi ADXN|Accounting Book Value Bawat Bahagi ALZN|CYCN (Cyclerion Therapeutics) - Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi protagenic.com (PTIX)|Book Value Bawat Bahagi KTTA|Cortigent Inc - Net Assets Bawat Bahagi|Avenue Therapeutics, Inc - Netong Asset Bawat Isang Bahagi|BrainStorm Cell Therapeutics Inc. (BCLI) - Book Value Bawat Bahagi|CARA - Accounting Book Value Bawat Bahagi|CHRO (chromocell.com) - Book Price ng Bahagi|Netong Asset Bawat Isang Bahagi Eliem Therapeutics, Inc. (ELYM)|Stockholders Equity Bawat Bahagi Intra-Cellular|Longboard Pharma - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Marinus Pharma MRNS|Accounting Book Value Bawat Bahagi NKGN (NKGen Biotech, Inc.)|neurobopharma.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Sage Therapeutics (SAGE)|SNPX: Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi TRVN|Vigil Neuroscience, Inc. (VIGL) - Net Asset Value Bawat Bahagi|WENA: Book Value Bawat Bahagi|Net Assets Bawat Bahagi CERE